Navigation Links
3SBio Inc. Announces Unaudited First Quarter 2012 Results
Date:5/13/2012

in 2011. The increase is mainly attributable to increased sales efforts and marketing activities, including the expansion of our sales & marketing team from 417 as of March 31, 2011 to 497 as of March 31, 2012.
  • General and administrative expenses. General and administrative expenses for the first quarter of 2012 were RMB16.8 million (US$2.7 million), or 11.4% of net revenues, compared to RMB15.6 million (US$2.4 million), or 13.2% of net revenues for the same period in 2011.  The decrease in general and administrative expenses as a percentage of net revenues is mainly due to improved economies of scale.
  • Operating income.  Operating income was RMB35.5 million (US$5.6 million) for the first quarter of 2012, a 40.2% increase from operating income of RMB25.3 million (US$3.9 million) for the same period in 2011. Operating margin for the first quarter of 2012 was 24.2%, a 2.8% increase from operating margin of 21.4% for the same period in 2011. The improved operating margin is primarily due to improved gross margins and stable administrative overheads. 

    Interest income. Net interest income was RMB5.4 million (US$0.9 million) for the first quarter of 2012, compared to RMB3.6 million (US$0.6 million) for the same period in 2011.

    Net income. Net income was RMB32.6 million (US$5.2 million) for the first quarter of 2012, a 47.1% increase over net income of RMB22.2 million (US$3.4 million) for the same period in 2011. Net income per ADS on a fully-diluted basis for the first quarter of 2012 increased to RMB1.44 (US$0.23) compared to RMB0.99 (US$0.15) for the same period in 2011. Net margin for the first quarter of 2012 was 22.2%, a 3.5% increase over net margin of 18.7% for the same period in 2011. 

    Cash Balances. Cash, cash equivalents and time deposits were RMB790.8 million (US$125.6 million, including restricted cash of RMB0.7 m
    '/>"/>

    SOURCE 3SBio Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2011
    2. 3SBio Inc. to Present at the UBS Greater China Conference 2012
    3. 3SBio Inc. Announces Results of 2011 Annual General Meeting
    4. 3SBio Inc. Announces Unaudited First Quarter 2011 Results
    5. 3SBio Inc. Schedules Unaudited First Quarter 2011 Results
    6. 3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results
    7. 3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP
    8. 3SBio Inc. Announces Unaudited Third Quarter Results
    9. 3SBio Inc. Announces Unaudited Second Quarter Results
    10. 3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results
    11. 3SBio Inc. Announces Filing of Form 20-F With SEC
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: ... develops and commercializes proprietary technologies and products for ... has received approval from the TSX Venture Exchange ... share purchase warrants ("the Warrants") of the Company, ... May 2013 private placement financing. Each ...
    (Date:4/17/2015)... 17, 2015  US-Australian drug discovery company, Novogen, today ... Understanding with the Feinstein Institute for Medical Research ... to collaborate with the objective of developing ... collaboration brings together the drug discovery expertise of ... the Feinstein Institute in neurosciences and oncology. ...
    (Date:4/17/2015)... 2015 LC Sciences LLC, a ... today that it is seeking beta testers for ... PCR based targeted sequencing technology. The system offers ... enables accurate detection of rare variants. It utilizes ... The company will collaborate with beta testers to ...
    (Date:4/16/2015)... Spirax Sarco, the leader in ... newly designed, state-of-the-art website in the first quarter ... promotes the Spirax Sarco brand, company capabilities, and ... a site visitor might be looking for including ... serviced, the latest company news, careers, and much ...
    Breaking Biology Technology:SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Spirax Sarco website has a new look 2
    ... BEIJING, July 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex:, ... in China, announced today,that its Annual General Meeting originally scheduled ... , At the July 16, 2009 ... outstanding shares was not present. In accordance with Antigua,law, the ...
    ... week are marking major breakthroughs in the effort to ... than 200 million people worldwide and causes long-term debilitating ... documents a multinational success, led by a team at ... the genome of the Schistosoma mansoni blood fluke, which ...
    ... , , , ... that it had closed its series A financing round. The infusion of capital ... that converts a wide variety of cellulosic materials (such as algae, plants and ... , As part of the agreement, the lead investor has joined ...
    Cached Biology Technology:Sinovac Adjourns 2008 Annual General Meeting 2UCSF researchers help crack parasite genome, identify drug leads 2UCSF researchers help crack parasite genome, identify drug leads 3
    (Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
    (Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
    (Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
    Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2
    ... the first researchers to study the deadly link between ... Association lifetime achievement award today at a ceremony in ... endocrinologist James Sowers, MD, recognizes his more than 30 ... The Irvine Page-Alva Bradley Lifetime Achievement Award in ...
    ... it they,re very good at what they do. But ... out inspection work in oily or dangerous environments, or in ... they,re one of the fastest and most maneuverable creatures on ... speeds due to their streamlined bodies and a finely tuned ...
    ... , New Rochelle, NY, September 19, 2012 Many ... will largely be based on the field of ... News ( GEN ) ( http://genengnews.com ). ... larger arrays of biosamples, demand is exceeding supply, ...
    Cached Biology News:Pioneering researcher receives Heart Association Lifetime Achievement Award 2Pioneering researcher receives Heart Association Lifetime Achievement Award 3Robotic tuna is built by Homeland Security 2
    Nuclear/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
    Cytosol/Particulate Rapid Separation Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: 4C...
    Request Info...
    Purified anti-human CD182 (CXCR2)...
    Biology Products: